We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App

Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure

By HospiMedica International staff writers
Posted on 18 Apr 2024
Print article
Image: The catheter is equipped with a microchip (Photo courtesy of Autonomix Medical)
Image: The catheter is equipped with a microchip (Photo courtesy of Autonomix Medical)

The peripheral nervous system (PNS) serves as the communication network that links the brain and spinal cord to every other part of the body. It consists of two parts: the somatic nervous system, which governs voluntary movement and sensory information, and the autonomic nervous system, which manages involuntary functions like heart rate and digestion. Essentially, the PNS is critical in almost all diseases due to its role in signal transmission throughout the body. Problems such as overactivity, disruption, or dysfunction in the PNS can lead to numerous health issues, including pain, cardiovascular diseases like hypertension, and gastrointestinal disorders. Now, a first-in-class technology platform comprising a catheter-based microchip sensing array can detect and differentiate neural signals as well as perform nerve ablations, killing the nerves that are misfiring to relieve pain. This technology can sense individual neural signals with sensitivity up to 3,000 times greater than current methods, revolutionizing the field of electrophysiology and pain management.

Autonomix Medical’s (The Woodlands, TX, USA) catheter-based technology offers a comprehensive solution by combining the detection and treatment of nerve-related disorders in a single procedure, thereby streamlining the process and enhancing patient outcomes. This two-fold technology operates with the precision of a smart bomb, allowing physicians to accurately target specific target nerves that are misfiring and eliminate them through ablation or burning to relieve pain. This method is superior to conventional treatments used by doctors to treat suspected areas by attempting to hit the right nerves that can be imprecise, miss the intended nerves, and damage the surrounding ones.

Autonomix’s breakthrough technology employs its proprietary microchip and a unique antenna sensing array to deliver accurate treatments via a safe and simple transvascular procedure. The microchip converts signals from the body into digital signals sent directly to a computer screen. This eliminates the need for the faint neural signals to travel through several feet of wires and allows them to be read on the spot. The sensing antenna can detect exceptionally weak neural signals, as low as 0.5 microvolts, compared to the 10-15 microvolts required by existing technologies. Its novel basket design allows locating neural signals in a 3D space to enable the highest level of precision treatment. This technology is applicable for treating various diseases associated with nervous system dysregulation. Initially, Autonomix is focusing on alleviating pain in patients with pancreatic cancer or pancreatitis, who do not find relief from current treatments. The company has secured a US patent for its proprietary catheter-based technology for managing cancer-related pain.

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Silver Member
Compact 14-Day Uninterrupted Holter ECG

Print article


Surgical Techniques

view channel
Image: The multi-sensing device can be implanted into blood vessels to help physicians deliver timely treatment (Photo courtesy of IIT)

Miniaturized Implantable Multi-Sensors Device to Monitor Vessels Health

Researchers have embarked on a project to develop a multi-sensing device that can be implanted into blood vessels like peripheral veins or arteries to monitor a range of bodily parameters and overall health status.... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.